newsfilter
← Latest News
Business Wire·

Auna Announces 3Q25 Financial Results

  • Auna reported third quarter 2025 consolidated revenue of S/1,117 million, reflecting a 1% increase in foreign exchange-neutral terms but a 1% decrease year-over-year on a reported basis.
  • Adjusted EBITDA declined 5% in foreign exchange-neutral terms and 7% year-over-year to S/232 million, resulting in an adjusted EBITDA margin of 20.8%, down 1.3 percentage points from the prior year.
  • Adjusted net income fell to S/58 million from S/75 million in the same period last year, while net income decreased to S/53 million from S/101 million.
  • The company's leverage ratio remained stable at 3.6x Net Debt-to-Adjusted EBITDA, with management targeting a reduction below 3x in the medium term.
  • Peru achieved substantial growth in local currency, driven by increased memberships, pricing adjustments, improved oncology MLR to 49.3%, and higher demand in emergency visits.
  • Colombia delivered double-digit growth in adjusted EBITDA in local currency, supported by expanded risk-sharing PGP models, reduced exposure to intervened payors, and higher surgery tickets.
  • Mexico experienced revenue and profitability declines due to weaker demand for procedures, legacy relationship challenges, implementation issues with new hospital information systems, and currency depreciation of the Mexican Peso.
  • Despite financial headwinds in Mexico, the number of surgeries, oncology services, and cardiology services increased for the second consecutive quarter.
  • Auna completed a USD 765 million debt refinancing after the quarter-end to extend maturities, reduce interest costs, and strengthen its capital structure.
  • The company highlighted strategic partnerships with Sojitz and progress on the Trecca milestone to support growth in Mexico.
  • A conference call to discuss these results is scheduled for November 21, 2025, at 8:00 a.m. Eastern time.